Navigation Links
Arbor Vita presents new data on cancer diagnostic at EUrogin
Date:11/14/2008

NICE, FRANCE, November 14 , 2008 Arbor Vita Corporation (AVC), a privately held biopharmaceutical company, presented new data today on its rapid, point-of-care prototype HPV test with a high positive predictive value for cervical cancer and pre-cancer. Targeted for use throughout the developing world, this diagnostic test is being developed in partnership with PATH. The presentation, "Development of a Rapid Diagnostic Test for Cervical Pre-Cancer and Cancer," was given during the "Molecular Markers" session at Eurogin 2008, an international conference providing a comprehensive overview of current scientific advances in the field of cervical cancer control, including early detection.

AVC Vice President of Cervical Cancer Programs Johannes Schweizer, Ph.D., presented results of a prototype rapid cervical cancer diagnostic test that was designed using AVC's PDZ discovery platform. This E6 strip test, now in development, detects the E6 oncoprotein produced by the human papillomavirus (HPV), the principal cause of cervical cancer. E6 is a diagnostic marker of high positive predictive value for cervical cancer because of its clinically relevant activity. The test is engineered to specifically detect E6 oncoprotein of high-risk HPV which, in concert with E7, is necessary for oncogenic transformation of cervical epithelial cells.

Previously, AVC has demonstrated E6 specificity for detecting the HPV16 strain, which is responsible for approximately 50% of all cervical cancers. The new data expands this research to detect three different strains, HPV16, HPV18 and HPV45, which together account for 80% of cervical cancers. The ultimate goal of the project is to develop a multiplex test that detects the seven most prevalent HPV types which are known to progress to cervical cancer. The simple, easy-to-use test is designed to be used as a cancer-screening tool in low resource settings such as in developing countries, where appropriate methods for screening for cervical pre-cancer and cancer are still insufficient.

Dr. Schweizer commented, "Early detection of cancer-causing HPV infection is critical for the potential prevention and/or treatment of cervical cancer. Although only a very small number of HPV infections progress to cervical cancer, monitoring the E6 protein level because of its cancer-causing activity may prove to be a simple and cost-efficient test to identify women at risk for cervical cancer."


'/>"/>

Contact: Debra Bannister
debra.bannister@arborvita.com
530-676-8001
Arbor Vita Corporation
Source:Eurekalert

Related biology news :

1. Cold Spring Harbor Protocols features organ and cell culture methods
2. Mercury pollution causes immune damage to harbor seals
3. Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer
4. Arbor Vita and WRAIR sign CRADA for traumatic brain injury collaboration
5. Heavy metal link to mutations, low growth and fertility among crustaceans in Sydney Harbor tributary
6. Shipwrecks on coral reefs harbor unwanted species
7. Cold Spring Harbor Protocols highlights gene silencing, cancer cell biology methods
8. A field guide to the landscape of Cold Spring Harbor Laboratory
9. Watson-inspired innovation in research at Cold Spring Harbor Laboratory
10. Cold Spring Harbor Protocols features methods for analyzing genomes and plant cells
11. Cold Spring Harbor Protocols features classic approaches for analyzing chromosomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published ... frozen and fresh in vitro fertilization (IVF) transfer cycles. The multi-center ... success. , After comparing the results from the fresh and frozen transfer cohorts, ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... recipients of 13 prestigious awards honoring scientists who have made ... in a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition ...
Breaking Biology Technology: